Previous 10 | Next 10 |
We review 5 top stock ideas that have been created by the Fed’s tomfoolery (3 are pure-growth stocks and 2 are dividend-growth stocks). We also discuss a big reason why cryptocurrency popularity continues to grow (hint: more Fed tomfoolery). We conclude with our opinion on ...
Tissuemed develops and markets adhesive films to prevent air, blood, and fluid leaks encountered in surgery. The commercial terms were not disclosed. Tissuemed's lead product, Tissuepatch™, is a proprietary sealant technology that bonds to tissue to help control internal bleeding or pr...
BD Acquires Tissuemed, Ltd. To Add Advanced Sealant To Its Portfolio Of Surgical Solutions - Acquisition complements BD's core portfolio - adding an innovative, broadly applicable surgical sealant to a suite of BD biosurgery products already relied upon in the operating room. ...
The 32 Dividend Kings lost 1.68% in November, underperforming the broad market once more this year. The 8 best dividend kings based on forecasted growth and valuation offered 36 bps of alpha in November. Since July, the buy and hold portfolio for this strategy has gained 528 bps o...
Piper Sandler analyst Jason Bednar has downgraded Becton Dickinson (NYSE:BDX) to Neutral from Overweight with a price target (PT) of $260, down from $285. Shares down 1.3% premarket at $247.05. The analyst sees a lack of catalysts for shares over at least the next six months along w...
We provide a summary of upcoming ex-dividend dates in a quick reference table. The table includes relevant data and key statistics as well as the next payout and pay date. We highlight a high-quality stock with an upcoming ex-dividend date for further research and possible investm...
Becton, Dickinson, and Company (NYSE:BDX) has selected "embecta" as the name for its Diabetes Care business which will become an independent, publicly-traded company after the completion of its previously announced spinoff. Post-spinoff, embecta will be led by CEO Devdatt (Dev) Kurdikar, as p...
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion, Contender, An...
Monthly update of the Dividend Champions List. 75 companies declared higher dividends in the past month, with an average increase of 8.55% over their previous payouts. Eight new Contenders, and two new Challengers. For further details see: Dividend Champions For December...
All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 11.9% and a median increase of 5.4%. YTD, I've tracked 479 increases. There are 11 increases for next week, down from 29 last week...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
2024-08-02 11:15:08 ET Raymond James analyst issues OUTPERFORM recommendation for BDX on August 2, 2024 09:49AM ET. The previous analyst recommendation was Outperform. BDX was trading at $239.0875 at issue of the analyst recommendation. The overall analyst consensus : BU...
2024-08-02 10:10:00 ET August 2, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Tech, Automotive, Biotech and Retail Sectors. The newest automotive stocks are involved in r...
2024-08-02 09:00:11 ET Larry Biegelsen from Wells Fargo issued a price target of $280.00 for BDX on 2024-08-02 08:16:00. The adjusted price target was set to $280.00. At the time of the announcement, BDX was trading at $236.01. The overall price target consensus is at $2...